Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases

  • C D Klemke
  • N Booken
  • C Weiss
  • J P Nicolay
  • S Goerdt
  • M Felcht
  • C Géraud
  • W Kempf
  • C Assaf
  • N Ortonne
  • M Battistella
  • M Bagot
  • R Knobler
  • P Quaglino
  • B Arheiliger
  • M Santucci
  • P Jansen
  • M H Vermeer
  • R Willemze

Abstract

BACKGROUND: Patients with erythrodermic disease are a diagnostic challenge regarding the clinical and histological differential diagnosis.

OBJECTIVES: To evaluate histopathological and immunohistochemical diagnostic markers for Sézary syndrome.

METHODS: Ninety-seven erythrodermic cases [Sézary syndrome (SS), n = 57; erythrodermic inflammatory dermatoses (EIDs), n = 40] were collected by the EORTC Cutaneous Lymphoma Task Force histopathology group. Evaluation criteria were (i) epidermal and dermal changes; (ii) morphology of the infiltrate; (iii) immunohistochemical analysis of marker loss (CD2, CD3, CD4, CD5 and CD7); (iv) bystander infiltrate by staining for CD8, FOXP3 and CD25; and (v) expression of Ki-67, CD30, PD-1 and MUM-1.

RESULTS: The workshop panel made a correct diagnosis of SS in 51% of cases (cutaneous T-cell lymphoma 81%) and of EID in 80% without clinical or laboratory data. Histology revealed a significantly increased degree of epidermotropism (P < 0.001) and more intraepidermal atypical lymphocytes (P = 0.0014) in SS biopsies compared with EID. Pautrier microabscesses were seen only in SS (23%) and not in EID (P = 0.0012). SS showed significantly more dermal cerebriform and blastic lymphocytes than EID. Immunohistochemistry revealed a significant loss of CD7 expression (< 50%) in 33 of 51 (65%) cases of SS compared with two of 35 (6%) EID (P < 0.001). The lymphocytic infiltrate in SS skin samples was found significantly to express PD-1 (P = 0.0053), MUM-1 (P = 0.0017) and Ki-67 (P < 0.001), and showed less infiltration of CD8(+) lymphocytes (P < 0.001). A multivariate analysis identified CD7 loss, increased numbers of small cerebriform lymphocytes, low numbers of CD8(+) lymphocytes and increased proliferation (Ki-67(+) lymphocytes) as the strongest indicators for the diagnosis of SS.

CONCLUSIONS: A number of different histological and immunophenotypical criteria are required to differentiate between SS and EIDs.

Bibliografische Daten

OriginalspracheEnglisch
ISSN0007-0963
DOIs
StatusVeröffentlicht - 07.2015

Anmerkungen des Dekanats

© 2015 British Association of Dermatologists.

PubMed 25864856